Infectious Disease

Genbody COVID-19 POC Ag

The GenBody COVID-19 Ag is an immunochromatographic rapid diagnostic test (RDT) intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal (NP) or anterior nasal (AN) swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first six days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested at least three times over five days with at least 48 hours between tests.
 
Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high, or waived complexity tests. This product is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance or Certificate of Accreditation. 

Ordering Information

PRODUCT

Tests Per Kit

ITEM #

Genbody COVID-19 POC Ag

25

#COVAGO25-NU

PRODUCT

Kits Per Carton

ITEM #

Genbody COVID-19 POC Ag

36

#COVAGO25-NU

PRODUCT

Cartons Per Pallet

ITEM #

Genbody COVID-19 POC Ag

12

#COVAGO25-NU

CALL 800-592-1041

- OR -

  • FDA EUA Authorized rapid antigen test
  • Anterior nasal swab specimen collection for comfort
  • Identifies acute infection with a 92.31% sensitivity and 99.04 specificity
  • Selected by NIH for the Rapid Acceleration of Diagnostics, for US production of the GenBody COVID-19 Ag test
  • Large manufacturing capacity and immediately available for distribution
  • For use in the Point-of-Care setting
  • FDA EUA Authorized rapid antigen test
  • Anterior nasal swab specimen collection for comfort
  • Identifies acute infection with a 92.31% sensitivity and 99.04 specificity
  • Selected by NIH for the Rapid Acceleration of Diagnostics, for US production of the GenBody COVID-19 Ag test
  • Large manufacturing capacity and immediately available for distribution
  • For use in the Point-of-Care setting

BDSC Company is a US-based, global healthcare supply company committed to bringing clinical innovation & financial impact into the healthcare and retail markets domestically and abroad.

BDSC Company offers a range of ordering options. If you would like to speak to a BDSC expert immediately, contact us on 800-592-1041. If you prefer to enquire online, please click on ‘Get A Quote’ above.

Innovation - Opportunity - Disruption
Contact Us
Copyright© 2023 BDSC Company - All Rights Reserved.